Pro Medicus Limited
PME.AXHealthcareASXHealth Information Services · Last scanned May 30, 2026
Scan Results
Daily timeframePart of the healthcare sector, Pro Medicus Limited (PME.AX) is listed under Health Information Services. At a $13.82B market cap, Pro Medicus Limited ranks as a large-cap company within healthcare. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software.
Market Cap
$13.82B
Beta
0.59
P/E (TTM)
59.04
P/E (Fwd)
71.01
EPS (TTM)
$2.25
EPS (Fwd)
$1.86
ROE
76.8%
ROA
27.0%
Cash
$221.8M
Total Debt
$2.5M
Free CF
$102.7M
52W Change
-53.1%
Annual Financials
Cash vs Debt
Pro Medicus Limited holds $221.8M in cash against $2.5M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $102.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 76.8% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 27.0% further supports the picture of efficient asset utilization. Revenue has grown from $93.4M (2022) to $212.9M (2025), reflecting a 128% increase over the period.
PME.AX's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. With cash comfortably exceeding debt, PME.AX has financial flexibility that may help navigate uncertain periods. At over 50x earnings, PME.AX carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing PME.AX.